DPP-4 inhibitors increase the endogenous GLP-1 concentrations ~2-3-fold, GLP-1 receptor agonists lead to 8-10-fold concentrations
Can Smaller Companies Make It in the GLP-1 Market
Trials conducted more recently have been of much shorter duration, typically lasting about one to three months
Sample lots from 50 vials
For deeper context on wound repair research with peptides, see our guide on BPC-157 wound healing research and our overview of peptides for joint and tendon repair research
Meded Fak Land Bouwkun Digeen Toegep Biol Wet 66:227232 Nagarajan S, Nagarajan R, Kumar J, Salemme A, Togna A, Saso L, Bruno F (2020) Antioxidant activity of synthetic polymers of phenolic compounds